Clinical trial
Novel Biomarkers for Personalized Therapy in Korean Patients With Ischemic Stroke
NCT01429948 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Biomarkers for Personalized Therapy in Korean Patients With Ischemic Stroke
- Lead sponsor
- Samsung Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2008
- Completion date
- May 31, 2011
- Enrollment
- 581 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.